Wilbanks Smith & Thomas Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $601K | Sell |
6,897
-1,273
| -16% | -$109K | 0.02% | 319 |
|
|
2023
Q4 | $673K | Buy |
8,170
+1,461
| +22% | +$111K | 0.02% | 291 |
|
|
2023
Q3 | $526K | Buy |
6,709
+450
| +7% | +$37.7K | 0.02% | 305 |
|
|
2023
Q2 | $551K | Sell |
6,259
-394
| -6% | -$33.9K | 0.02% | 298 |
|
|
2023
Q1 | $536K | Buy |
6,653
+3,072
| +86% | +$250K | 0.02% | 294 |
|
|
2022
Q4 | $278K | Sell |
3,581
-2,471
| -41% | -$200K | 0.01% | 398 |
|
|
2022
Q3 | $489K | Sell |
6,052
-347
| -5% | -$31.2K | 0.02% | 292 |
|
|
2022
Q2 | $574K | Buy |
6,399
+501
| +8% | +$50.8K | 0.02% | 273 |
|
|
2022
Q1 | $608K | Buy |
5,898
+2,492
| +73% | +$263K | 0.02% | 278 |
|
|
2021
Q4 | $352K | Sell |
3,406
-104
| -3% | -$12K | 0.01% | 378 |
|
|
2021
Q3 | $440K | Sell |
3,510
-113
| -3% | -$14.6K | 0.02% | 327 |
|
|
2021
Q2 | $450K | Buy |
3,623
+27
| +0.8% | +$3.39K | 0.02% | 328 |
|
|
2021
Q1 | $425K | Buy |
3,596
+20
| +0.6% | +$2.34K | 0.02% | 312 |
|
|
2020
Q4 | $419K | Sell |
3,576
-100
| -3% | -$11K | 0.02% | 285 |
|
|
2020
Q3 | $382K | Sell |
3,676
-86
| -2% | -$8.64K | 0.02% | 281 |
|
|
2020
Q2 | $345K | Sell |
3,762
-172
| -4% | -$16.5K | 0.02% | 286 |
|
|
2020
Q1 | $355K | Buy |
3,934
+1,512
| +62% | +$161K | 0.03% | 261 |
|
|
2019
Q4 | $275K | Buy |
2,422
+82
| +4% | +$9K | 0.02% | 344 |
|
|
2019
Q3 | $254K | Buy |
2,340
+167
| +8% | +$17.4K | 0.02% | 348 |
|
|
2019
Q2 | $212K | Buy |
+2,173
| New | +$198K | 0.01% | 390 |
|
|
2019
Q1 | – | Sell |
-2,360
| Closed | -$215K | – | 416 |
|
|
2018
Q4 | $215K | Buy |
2,360
+183
| +8% | +$17.1K | 0.01% | 319 |
|
|
2018
Q3 | $214K | Buy |
+2,177
| New | +$201K | 0.01% | 379 |
|
|
2018
Q2 | – | Sell |
-3,117
| Closed | -$250K | – | 359 |
|
|
2018
Q1 | $250K | Buy |
+3,117
| New | +$257K | 0.02% | 289 |
|
|
2017
Q3 | – | Sell |
-2,479
| Closed | -$220K | – | 346 |
|
|
2017
Q2 | $220K | Sell |
2,479
-815
| -25% | -$68.7K | 0.02% | 291 |
|
|
2017
Q1 | $265K | Buy |
3,294
+95
| +3% | +$7.42K | 0.02% | 266 |
|
|
2016
Q4 | $228K | Buy |
+3,199
| New | +$251K | 0.02% | 266 |
|
|
2016
Q2 | – | Sell |
-2,832
| Closed | -$212K | – | 301 |
|
|
2016
Q1 | $212K | Hold |
2,832
| – | – | 0.03% | 263 |
|
|
2015
Q4 | $218K | Buy |
+2,832
| New | +$213K | 0.02% | 247 |
|
|
2015
Q3 | – | Sell |
-3,444
| Closed | -$255K | – | 290 |
|
|
2015
Q2 | $255K | Sell |
3,444
-59
| -2% | -$4.51K | 0.03% | 259 |
|
|
2015
Q1 | $273K | Buy |
+3,503
| New | +$266K | 0.03% | 246 |
|
Other funds holding MDT
Wilbanks Smith & Thomas Asset Management's MDT Position: Q1 2024 in Review
Wilbanks Smith & Thomas Asset Management reduced its Medtronic (MDT) stake by 16% in Q1 2024, selling an estimated $109K and leaving 6,897 shares worth $601K. The position accounts for 0.02% of the portfolio, ranked #319.
Wilbanks Smith & Thomas Asset Management first reported a position in MDT in Q1 2015 and has held it in 30 quarters since. The position peaked at $673K in Q4 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Wilbanks Smith & Thomas Asset Management held 6,897 shares of Medtronic worth $601K as of Q1 2024.
- Wilbanks Smith & Thomas Asset Management sold 1,273 Medtronic shares in Q1 2024, an estimated $109K.
- Medtronic made up 0.02% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #319 holding.
- Wilbanks Smith & Thomas Asset Management first reported a position in Medtronic in Q1 2015 and has held it in 30 quarters since.
- Wilbanks Smith & Thomas Asset Management's Medtronic position peaked at $673K in Q4 2023.
- 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.